| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1723190A Polymorphic forms of nateglinide |
| 01/18/2006 | CN1723059A Insulin receptor activators for the treatment of human body metabolic disorder resulting from treatment of HIV infection with HIV protease inhibitors |
| 01/18/2006 | CN1723035A Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 01/18/2006 | CN1723034A Composition and method for treating diabetes |
| 01/18/2006 | CN1723019A Compounds having anti-proliferative properties |
| 01/18/2006 | CN1723016A Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging |
| 01/18/2006 | CN1723015A Fatigue reducing agent |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721413A Barbituric acids and their preparation process and use |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1720982A Sugar decreasing composition of fenugreek seed |
| 01/18/2006 | CN1720979A Method for preparing capsule for regulating blood pressure and blood sugar |
| 01/18/2006 | CN1720958A Medicine for treating hyperlipemia, and hypertension and high blood viscosity |
| 01/18/2006 | CN1720957A Blood fat regulating Chinese medicinal composition, its preparation and using method |
| 01/18/2006 | CN1720953A Method for preparing gene-caring weight-reducing medicine |
| 01/18/2006 | CN1720942A Preparation of lymphatic static fat-expelling weight-reducing externally applied cream and its using method |
| 01/18/2006 | CN1720941A Compound medicinal preparation with clopidogrel and red rice extracts and application thereof |
| 01/18/2006 | CN1720935A Yew preparation and method for preparing the same |
| 01/18/2006 | CN1720912A Pharmaceutical compositions |
| 01/18/2006 | CN1237168C New acid resistant and cholate resistant lactobacillus isolated strain having reducing and assimilating cholesterol ability |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237071C Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/18/2006 | CN1237066C Antihyperglycemic and oxidation resistant health products and preparing process thereof |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236831C Compositions for protein delivery via the pulmonary route |
| 01/18/2006 | CN1236795C Medicinal preparation of traditional Chinese medicine for treating diabetes and its production method |
| 01/18/2006 | CN1236764C Method for preparing a composition |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/18/2006 | CN1236757C Slimming composition contg. substance inducing IL-6 production |
| 01/17/2006 | US6987131 Phenylacetic acid compositions for treating or preventing hypercholesterolemia |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987118 peroxisome proliferator activator receptor agonists; anticholesterol, antidiabetic agents; 2-Methyl-2-{2-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carbonyl]-1,2,3,4-tetrahydro-isoquinolin-7-yloxy}-propionic acid |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | US6987098 Health supplement |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6986996 Using anti-heparanase antibody to bind heparanase encoded by amino acid sequence no.1 for monitoring heparanase protein expression of heparanase gene in white blood cells in vitro; drug delivery targets; diagnosis of tumors, cancer and metastasis |
| 01/17/2006 | CA2346171C Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 01/17/2006 | CA2338792C Rapidly disintegrable solid preparation |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2129079C Orally administrable cholesterol lowering agent |
| 01/12/2006 | WO2006004574A2 Method for using gamma cyclodextrin to control blood glucose and insulin secretion |
| 01/12/2006 | WO2006003909A1 Fat combustion accelerator |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | WO2006002453A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 01/12/2006 | WO2004089951A8 Imidazopyridine derivatives having an affinity for melanocortin receptors |
| 01/12/2006 | WO2004080401A3 Oral insulin therapies and protocol |
| 01/12/2006 | US20060009534 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009516 Use of ingap for reversing diabetes |
| 01/12/2006 | US20060009514 Method for treating obesity |
| 01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009459 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008857 Cap-binding protein |
| 01/12/2006 | US20060008574 Galactosyl isomalt, method for production and use thereof |
| 01/12/2006 | DE19961182B4 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 01/12/2006 | DE102004030502A1 Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel New imidazoles and triazoles, their preparation and use as medicaments |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572540A1 Arylalkylamine vanadium (v) salts for the treatment and/or prevention of diabetes mellitus |
| 01/12/2006 | CA2572163A1 Pyrazole derivatives |
| 01/12/2006 | CA2572031A1 Fat combustion accelerator |
| 01/12/2006 | CA2571957A1 Methods and compositions using cd3 agonists |
| 01/12/2006 | CA2570268A1 Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients |
| 01/12/2006 | CA2547934A1 Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |
| 01/11/2006 | EP1614418A1 use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
| 01/11/2006 | EP1614416A2 Method for treating amyloidosis |
| 01/11/2006 | EP1613628A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613589A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
| 01/11/2006 | EP1613332A2 Formulations for mediating inflammation and for reducing blood cholesterol |
| 01/11/2006 | EP1613326A1 (3-{3-´(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/11/2006 | EP1613318A2 Compounds and their use to treat diabetes and related disorders |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1399130A4 Emulsion and dispersion formulations and method |
| 01/11/2006 | EP1395572B1 Process for preparing a thiazole ppar-ligand and polymorphs thereof |